'COVID toes': A true viral phenomenon or a diagnosis without a leg to stand on?Capsule Summary

Autor: Jia C. Gao, MD, Alisen Huang, MD, Ankuri Desai, MD, PhD, Bijan Safai, MD, Shoshana Marmon, MD, PhD

Publikováno v: JAAD International, Vol 9, Iss , Pp 1-6 (2022)

“COVID toes” is the colloquial name of chilblain-like lesions thought to be a sequela of COVID-19 infection. Over two years and approximately 300 publications later, this association remains controversial. Here, we summarize key clinical, serolog

Externí odkaz: https://doaj.org/article/b49364e2790d4368915635f582f0ce64

Evidence for the use of mouthwash as a preprocedural preventive measure against COVID-19: Should we rinse and repeat?

Autor: Jia C. Gao, BS, Channing Hood, MD, Bijan Safai, MD, Shoshana Marmon, MD, PhD

Publikováno v: JAAD International, Vol 6, Iss , Pp 109-110 (2022)

Externí odkaz: https://doaj.org/article/652c7150a4a94b34a366e58b1c2b5d20

Evaluating calcipotriene 0.005% foam for the treatment of plaque psoriasis of the scalp and body in patients aged 12 years and older

Autor: Lindsay C. Strowd, Steven R. Feldman, Jia C Gao, Veronica K. Emmerich

Publikováno v: Gao, J C, Emmerich, V K, Feldman, S & Strowd, L C 2021, ' Evaluating calcipotriene 0.005% foam for the treatment of plaque psoriasis of the scalp and body in patients aged 12 years and older ', Expert Opinion on Pharmacotherapy, vol. 22, no. 5, pp. 543-547 . https://doi.org/10.1080/14656566.2020.1853099

Introduction: Topical corticosteroids are the mainstay of treatment for mild-to-moderate psoriasis in adult and adolescent patients but there can be many adverse events associated with long-term corticosteroid use. Corticosteroid-sparing alternatives

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf113e8e6877a0c1df4d5a10a940187a
https://doi.org/10.1080/14656566.2020.1853099

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis

Autor: Jia C Gao, Albert G Wu, Marissa N Contento, Jacqueline M Maher, Abigail Cline

Publikováno v: Clinical, cosmetic and investigational dermatology. 15

Small molecule medications like apremilast are emerging as promising options for patients with psoriasis and other inflammatory conditions. Apremilast was approved by the Food and Drug Administration in 2014 for the management of both psoriasis and p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a026790fe3e92294a35ee558fa12612
https://pubmed.ncbi.nlm.nih.gov/35300435